Yayınlar & Eserler

Makaleler 180
Tümü (180)
SCI-E, SSCI, AHCI (135)
SCI-E, SSCI, AHCI, ESCI (148)
ESCI (12)
Scopus (146)
TRDizin (36)
Diğer Yayınlar (20)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 270

1. Variations in F-18-FMISO Physiological Uptake

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

3. Correlation Between PRIMARY Scores in Ga-68 PSMA PET and Histological ISUP Grades in Prostate Cancer

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)

12. Transarterial radioembolization (TARE) in Colorectal metastasis of liver (TACOME) trial

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.407-408, (Tam Metin Bildiri)

13. F18-FCH uptake in thyroid parenchymal diseases

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.367-368, (Tam Metin Bildiri)

14. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.17, (Tam Metin Bildiri)

17. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

Annual Congress of the European Association of Nuclear Medicine October 19–23, 2024 Hamburg, Germany, Hamburg, Almanya, 19 Ekim 2024, cilt.51, ss.17, (Özet Bildiri) identifier identifier

18. Interim AnalysisAssessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET (ARTE-MISO Trial)

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri) identifier

24. Radioembolization with 90Y Resin Microspheres and Voxel-Based Dosimetry with Integrated 90Y PET/MRI

33rd Annual Conference of Asian Pacific Association for the Study of the Liver, Kyoto, Japonya, 27 Mart 2024, (Tam Metin Bildiri)

29. Prognostic value of F-18 FDG PET/CT metabolic parameters in prostate cancer patients

Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)

43. The Relationship between 18F-FCH uptake intensity and Cell Content in Parathyroid Lesions

35th Annual Congress of the European Association of Nuclear Medicine, Barselona, İspanya, 15 Ekim 2022, cilt.49, ss.136, (Özet Bildiri)

44. Head-to-head comparison of 18F-FDG PET/CT and PET/MRI for the imaging of peritoneal recurrence of ovarian carcinoma

Annuals Congress of the European Association of Nuclear Medicine, 2022, Barcelona, İspanya, 15 Ekim 2022, cilt.49, ss.191-192, (Özet Bildiri)

45. DBBHL’Lİ Olguda Nadir Ekstranodal Tutulumlar

34.Ulusal Nükleer Tıp Kongresi, 27 Mart 2022, cilt.8, ss.157-158, (Özet Bildiri)

49. Added value of F18-FDG PET/MR imaging for detecting liver metastases in patients with colorectal cancer

Annuals Congress of the European Association of Nuclear Medicine, 20 Ekim 2021, cilt.48, ss.184, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

52. PETMR in Clinical Practive

Vertual 2021 MEFOMP Medical Physics Congerence, 5 - 07 Nisan 2021

54. Diferansiye tiroid kanseri takibinde F-18-FDG PET/MR’xxnin PET/BT’xxye katkısı

32.Ulusal Nükleer Tıp Kongresi, Türkiye, 20 - 21 Kasım 2020, cilt.6, ss.30-31, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

56. ACCURACY AND RELIABILITY OF MEASUREMENTS OBTAINED FROM 3-DIMENSIONAL RABBIT MANDIBLE MODEL: A MICRO-COMPUTED TOMOGRAPHY STUDY

2. ULUSLARARASI TÜRKİYE VETERİNER ANATOMİ KONGRESİ 11. ULUSAL VETERİNER ANATOMİ KONGRESİ, 26 - 29 Ekim 2019, (Özet Bildiri)

64. Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) identifier

66. The Efficacy of 18F Choline PET/CT in comparison to Tc99m MIBI SPECT/CT in the Localisation of Hyperfunctioning Parathyroid Gland in primary Hyperparathyroidism

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) identifier

68. Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma: A single centre experience

28th International Congress of the European-Respiratory-Society (ERS), Paris, Fransa, 15 - 19 Eylül 2018, cilt.52, (Özet Bildiri) identifier

72. 18F-Florokolin ile radioguided paratiroidektomi

21.Ulusal Cerrahi Kongresi, Türkiye, 11 - 15 Nisan 2018, (Özet Bildiri)

83. Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivety?

SNMMI 2017 Annual Meeting, Denver, Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, ss.1078, (Özet Bildiri)

84. Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in testicular carcinoma

SNM Annual Meeting, Denver, Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, ss.1069, (Özet Bildiri)

86. Hayvan PET/BT görüntüleme deneyimimiz

29.Ulusal Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2017, cilt.3, ss.38, (Özet Bildiri)

87. N-13 Amonyak krdiyak PET görüntüleme: İlk deneyimler

29.Ulusal Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2017, cilt.3, ss.66, (Özet Bildiri)

88. N-13 amonyak kardiyak PET görüntüleme: ilk deneyimler

29.Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 10 - 14 Mayıs 2017, (Özet Bildiri)

89. Additive value of dynamic risk stratification in the management of differentiated thyroid carcinoma patients

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, (Özet Bildiri) identifier

90. Kastrasyon dirençli prostat kanserinde yeni moleküler görüntüleme ve yeni radyonüklid tedavi

Nöroendorkin tümörler ve prostat kanserlerinde ga-68 DOTATATE/Ga-68 PSMA görüntüleme ve Lu-177/Y-90 Tedavisi, Türkiye, 03 Şubat 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

95. Comparison of Survival, Safety and Efficacy After Chemo and Radioembolization of BCLC Stage B-C Hepatocellular Cancer Patients

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

96. Effect of application of prophylactic central compartment lymph node dissection to radioiodine ablation doses in patients with papillary thyroid carcinoma

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri) identifier

98. Evaluation of extrapulmonary Ga 67 uptake in sarcoidosis A retrospective analysis

Annual Congress of EANM, Hamburg, Almanya, 25 - 29 Nisan 2015, cilt.28, ss.436, (Özet Bildiri)

104. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Missouri, Amerika Birleşik Devletleri, 7 - 11 Haziran 2014, cilt.55, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

105. Correlation of tumor marker levels with intensity of FDG uptake on PET imaging in epithelial cancers.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

116. BASAL THYROGLOBULIN LEVELS MAY PREDICT RECURRENT AND PERSISTENT DISEASE IN DIFFERENTIATED THYROID CANCER (DTC)

37th Annual Meetingof the EuropeanThyroid Association, Leiden, Hollanda, 7 - 11 Kasım 2013, cilt.2, ss.75-194, (Özet Bildiri) identifier

121. The role of 18F-FDG PET/CT in pelviv and paraaortic lymph node staging of uterine cervical cancer

Annual Congress of the European Association of Nuclear Medicine, 27 - 31 Ekim 2012, cilt.39, ss.57, (Özet Bildiri) Sürdürülebilir Kalkınma

122. 18F-NaF PET/CT imaging in metastatic bone disease: Preliminary results from Turkey.

Annual Congress of the EANM 2012, 27 Ekim 2012, cilt.39, ss.474, (Özet Bildiri)

123. 68Ga DOTATATE accumulation in sarcoidosis

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) identifier

124. 18F-FDG PET/CT in Initial Staging of Gastric Cancer

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

125. The role of 18F-FDG PET/CT in pelvic and paraaortic lymph node staging of uterine cervical cancer

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

126. Predictive value of pre-transplant FDG-PET/CT in newly diagnosed multiple myeloma (MM) patients

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) identifier

127. 18F-NaF PET/CT Imaging in Metastatic Bone Disease: Preliminary Results from Turkey

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri) identifier

130. Availability of computer assisted real time ultrasonography for in-vivo and in-vitro monitoring ovarian structures in dogs

16th Annual Conference of the European-Society-for-Domestic-Animal-Reproduction (ESDAR), Dublin, İrlanda, 29 Ağustos - 01 Eylül 2012, cilt.47, ss.82, (Özet Bildiri) identifier

136. Prognostic value of post-induction PET/CT in untreated multiple myeloma (MM) patients undergoing autologous stem cell transplant (ASCT)

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) identifier

140. 18F NaF PET CT imaging in metastatic bone disease preliminary results

1st Balkan Congress of Nuclear Medicine, 4 - 08 Nisan 2012, ss.16, (Özet Bildiri)

144. The role of 18F FDG PET CT in the preoperative staging and post therapy follow up Comparison with spiral CT

International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Avusturya, 8 - 11 Kasım 2011, ss.86, (Özet Bildiri)

145. Intra arterial radioembolization with Y 90 for unresectable primary and metastatic liver tumours

International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Avusturya, 8 - 11 Kasım 2011, ss.199, (Özet Bildiri)

146. The role of PET/CT in the evaluation of panceratic cancer and suspected pancreas masses

International Congerence on Clinical PET and Molecular Nuclear Medicine, 8 - 11 Kasım 2011, ss.87, (Özet Bildiri) Sürdürülebilir Kalkınma

159. Impact of 18F FDG positron emission tomography computed tomography for detecting unknown primary tumor

SNM Annual Meeting, Texas, Amerika Birleşik Devletleri, 4 - 08 Haziran 2011, cilt.52, ss.1923, (Özet Bildiri)

170. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreas masses

Annual Congress of the European Association of Nuclear Medicine, 9 - 13 Ekim 2010, cilt.37, ss.432, (Özet Bildiri)

173. Is radioiodine treatment effective for childhood differentiated thyroid carcinomas: Results of five years follow up.

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) identifier

174. The role of 18F-FDG-PET CT in malign melanome and comparison with conventional imaging modalities

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) identifier

175. The retrospective analysis of SUV of lesions detected on 18F-FDG PET/CT in differentiated thyroid cancer

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

176. A comparison of 18F-FDG PET/CT with 111-IN octreotide scan in neuroendocrine tumors

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) identifier

177. Incidental thyroid lesions identified by F18 FDG-PET/CT imaging

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) identifier

196. Clinical experience of PET/CT in soft tissue and osseos sarcomes.

9th International Nuclear Oncology Congress, 25 Nisan 2010, cilt.19, ss.93, (Özet Bildiri)

197. Treatment of Unresectable Neuroendocrine Liver Tumors with Y-90 Microsphere

7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Berlin, Almanya, 11 - 12 Mart 2010, cilt.92, ss.42, (Özet Bildiri) identifier

215. Kadın Genital Tümörlerinde 18F FDG PET BT

21.Ulusal Nükleer Tıp Kongresi, Türkiye, 2 - 05 Mayıs 2009, cilt.18, ss.4

220. Kültüre edilmiş insan lenfosit hücreleri üzerine samariumun olası genotoksik etkisi

Uluslararası Katılımlı VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Türkiye, 6 - 09 Mayıs 2008

222. Tiroid karsinomalı bir olguda tüberkolaza sekonder yanlış pozitif F 18 FDG tutulumu

Türkiye Nükleer Tıp Kongresi, Türkiye, 27 - 30 Nisan 2008, cilt.17, ss.4, (Özet Bildiri)

224. The Value of PET CT for Staging in Head and Neck Carcinoma

20.Ulusal Nükleer Tıp Kongresi, Türkiye, 27 - 30 Nisan 2008, cilt.17, ss.6, (Özet Bildiri)

228. Calibration of I-131 in dose calibrators routinely used in nuclear medicine departments

20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri) identifier

229. Intraoperative gamma probe guided surgery with Tc99m pertechnetate in the completion thyroidectomy

20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri) identifier

235. The value of acei scintigraphy in patients with suspicious renovascular hypertansiyon

XIII.International Symposium of Radionuclides in Nephrourology, 9 - 13 Mayıs 2007, ss.3, (Özet Bildiri)

237. Kolorektal kanserde 18F FDG PET BT nin değeri

Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.7 Sürdürülebilir Kalkınma

239. F 18 FDG PET BT de yaygın tutulum izlenen sarkoidoz olguları

19.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.40

240. F 18 FDG PET BT de nsidental Rabdomyosarkom Tanımlanan Rektal Karsinom Olgusu

19.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.36

242. Alterations in sternal perfusion after internal thoracic artery harvesting: Mid-term results of scintigraphic study

16th World Congress of the Society of Cardio-Thoracic Surgeons, Ottowa, Kanada, 17 - 20 Ağustos 2006, cilt.1, ss.82, (Özet Bildiri)

248. Treatment for Microcarcinoma of the Thyroid Clinical Experience

52nd Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 16 - 18 Haziran 2005, cilt.46, ss.385

250. Transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy: safety, efficacy and outcome

31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35, (Özet Bildiri) identifier

256. Semiquantitative and qualitative evaluation of myocardial viability with Tl-201 reinjection SPECT and Tl-201 nitrate-augmented redistribution

17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri) identifier

257. Clinical importance of anti-TG autoantibodies (ATG) and MIBI scan in patients with thyroid carcinoma

17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri) identifier

258. Intraoperative Radioisotope Sentinel Lymph Node Mapping in Non Small Cell Lung Cencer

Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 19 - 23 Nisan 2004, cilt.45, ss.238

261. Akut myokard infarktüsü sonrası Tl 201 reverse redistribüsyon

Türkiye Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.10

264. Nöroendokrin tümörlerde In 111 oktreotid sintigrafisi sonuçları

Türkiye Nükleer tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.127

266. The value of the peritoneal scintigraphy in the evaluation of leakage complicating continuous ambulatory peritoneal dialysys.

50th Annual Meeting of the Society-of-Nuclear-Medicine, NEW ORLEANS, LOUISIANA, 21 - 25 Haziran 2003, cilt.44, (Özet Bildiri) identifier
Kitaplar 16

1. Nükleer Tıpta Tanı ve Tedavinin Geleceği

Nükleer Tıp ve Moleküler Görüntüleme, Mustafa Kibar, Editör, Akademisyen Kitabevi, ss.1503-1509, 2023

2. Radionuclide Therapy with Alpha-Emitting Agents in Bone Metastasis

Radionuclide Therapy , Recep Bekiş,Berna Polack,Murat Fani Bozkurt, Editör, Springer, London/Berlin , Geneve, ss.339-343, 2022

3. Medüller Tiroid Kanserinde Radyonüklid Görüntüleme ve Radyonüklid Tedaviler

Tiroid Kanseri Güncel Yaklaşım, Prof.Dr.Bekir Çakır, Editör, Akademisyen Kitapevi, ss.521-530, 2020 Sürdürülebilir Kalkınma

4. Parkinson Hastalığı Tanısında Nükleer Tıp Görüntüleme Yöntemleri

Hareket Bozuklukları ve Akıl Notları, Muhittin Cenk Akbostancı, Fatma Tuğra Karaarslan Türk, Editör, Güneş Tıp Yayınevi, ss.86-90, 2020

5. Kemik Metastazlarında Alfa Ajanları ile Radyonüklit Tedavi

Radyonüklid Tedavi, Prof.Dr.Recep Bekiş, Prof.Dr.Berna Polack, Prof.Dr.Murat Fani Bozkurt, Editör, O’xxTıp Kitapevi, ss.412-419, 2020

6. Göğüs Hastalıklarında Kullanılan Nükleer Tıp Yöntemleri

Göğüs Hastalıklarında Propedötik, Prof.Dr.Mehmet Karadağ, Prof.Dr.Akın Kaya, Prof.Dr.Tevfik Özlü, Editör, Dünya Tıp Kitapevi, ss.265-276, 2019

7. Nöroendokrin Neoplazilerde Peptid Reseptörlerle Radyonüklid Tedavi ve İzlemi

Türkiye Klinikleri Nükleer Tıp - Özel Konular, Prof.Dr.Zehra ÖZCAN, Editör, Dijital Akademi, Ankara, ss.49-52, 2018

8. Karaciğer Tümörlerinde İntraarteriyel Mikroküre Tedavisi Sonuçları

Türkiye Klinikleri Özel Konular - Primer ve Metastatik Karaciğer Tümörlerinde Radyonüklid Tedavi, Prof.Dr.K.Metin KIR, Editör, Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş., Ankara, ss.26-31, 2018

9. Nöroendokrin Neoplazilerde Peptid Reseptörlerle Radyonüklid Tedavi ve İzlemi

Türkiye Klinikleri Nükleer Tıp - Özel Konular, Prof.Dr.Zehra ÖZCAN, Editör, Dijital Akademi, ss.49-52, 2018

10. Tanı ve Tedavide İyotun Kullanımı

Her Yönü ile İyot, SELİM KURTOĞLU,FAHRİ BAYRAM, Editör, M Grup Matbaacılık , Ankara, ss.1-2, 2016

11. Göğüs Hastalıklarında Kullanılan Nükleer Tıp yöntemleri

Gögüs Hastalıkları Propedötik, KAYA AKIN, KARADAĞ MEHMET, ÖZLÜ TEVFİK, Editör, AVES yayıncılık, İstanbul, ss.207-214, 2014

12. Nükleer Tıp

Klinik Onkoloji El Kitabı, YALÇIN B, Editör, Günertıp Kitabevi , Ankara, ss.1, 2013

14. Pozitron Emisyon Tomografisi (PET)/Bilgisayarlı Tomografi (BT) ve Akciğer Hastalıklarında Kullanılan Diğer Nükleer Tıp Yöntemleri

Göğüs Hastalıkları, ÖZLÜ T, METİNTAŞ M, KARADAĞ M, KAYA A, Editör, Rotatıp Kitabevi, ss.217-220, 2012

15. Meme Kanserinde Nükleer Tıp Uygulamaları

Meme Kanseri, AYDIN SÜHA,AKÇA TAMER, Editör, Nobel Tıp Kitapevi, Ankara, ss.1-2, 2011

16. Ürolojik Tümörlerde PET'in Güncel Yeri

Ürolojide Yeni Ufuklar Üroonkoloji, BALTACI SÜMER, Editör, Güneştıp Kitabevi, Ankara, ss.1-2, 2009
Metrikler

Yayın

471

Yayın (WoS)

182

Yayın (Scopus)

148

Atıf (WoS)

1129

H-İndeks (WoS)

19

Atıf (Scopus)

1237

H-İndeks (Scopus)

21

Atıf (Sobiad)

3

H-İndeks (Sobiad)

1

Proje

37

Tez Danışmanlığı

3

Açık Erişim

38
BM Sürdürülebilir Kalkınma Amaçları